Harinder Singh
- Immunology top 0.05%
- T-cell and B-cell Immunology 59
- Immune Cell Function and Interaction 46
- Immunotherapy and Immune Responses 22
- Immune Response and Inflammation 10
- Molecular Biology top 0.1%
- Single-cell and spatial transcriptomics 13
- Genomics and Chromatin Dynamics 13
- RNA Research and Splicing 10
- Cancer Research top 0.5%
- NF-κB Signaling Pathways 14
- Hematology top 0.5%
- Oncology top 1%
- Co-authors
- Eric BertolinoPeter LasloJason X. ChengCornelis MurreSven HeinzChristopher BennerYin C. LinNathanael J. Spann
- Partner nations
- United StatesUnited KingdomIndia
In The Last Decade
Harinder Singh
119 papers receiving 23.1k citations
Hit Papers
Peers
Comparison fields: 5 of 158
- Immunology 9.4k
- Molecular Biology 14.0k
- Cancer Research 2.7k
- Hematology 1.8k
- Oncology 2.4k
Countries citing papers authored by Harinder Singh
This map shows the geographic impact of Harinder Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harinder Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harinder Singh more than expected).
Fields of papers citing papers by Harinder Singh
This network shows the impact of papers produced by Harinder Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harinder Singh. The network helps show where Harinder Singh may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Harinder Singh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 8 | |
| 6 | 2023 | 1 | |
| 7 | 2022 | 32 | |
| 8 | 2022 | 12 | |
| 9 | 2022 | 10 | |
| 10 | 2021 | 6 | |
| 11 | 2021 | 24 | |
| 12 | 2020 | 15 | |
| 13 | 2020 | 36 | |
| 14 | 2018 | 29 | |
| 15 | 2018 | 89 | |
| 16 | 2017 | 69 | |
| 17 | 2012 | 260 | |
| 18 | 2005 | 146 | |
| 19 | 1999 | 53 | |
| 20 | 1990 | 51 |
About Harinder Singh
Harinder Singh is a scholar working on Immunology, Transplantation, Cancer Research, Hematology and Molecular Biology, having authored 126 papers that have together received 23.4k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (59 papers), Immune Cell Function and Interaction (46 papers), Immunotherapy and Immune Responses (22 papers), NF-κB Signaling Pathways (14 papers), Single-cell and spatial transcriptomics (13 papers), Genomics and Chromatin Dynamics (13 papers), Immune Response and Inflammation (10 papers) and RNA Research and Splicing (10 papers). The work is most often cited by research in Immunology (9.4k citations), Molecular Biology (14.0k citations), Cancer Research (2.7k citations), Hematology (1.8k citations) and Oncology (2.4k citations). Harinder Singh has collaborated with scholars based in United States, United Kingdom and India. Frequent co-authors include Eric Bertolino, Peter Laslo, Jason X. Cheng, Cornelis Murre, Sven Heinz, Christopher Benner, Yin C. Lin, Nathanael J. Spann, Christopher K. Glass and Phillip A. Sharp. Their work appears in journals such as Nature Immunology, Molecular and Cellular Biology, Immunity, Cell Reports and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.